IL6 and stroke disorder: The inflammatory cytokines, tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), are generally considered to be representative contributors to neuroinflammation in ischemic stroke and are therefore promising potential targets in future stroke therapy (Lambertsen et al., 2019).